Free Trial

SELLAS Life Sciences Group (SLS) SEC Filings & 10K Form

SELLAS Life Sciences Group logo
$1.27 -0.04 (-3.05%)
Closing price 04:00 PM Eastern
Extended Trading
$1.27 0.00 (0.00%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent SELLAS Life Sciences Group SEC Filings

DateFilerForm TypeView
01/29/2025
10:25 AM
SELLAS Life Sciences Group (Filer)
Form 424B5
01/29/2025
8:14 AM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:42 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
3:11 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:30 PM
CICIC DRAGAN (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:30 PM
SELLAS Life Sciences Group (Issuer)
Varian John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:31 PM
Kalin Katherine Bach (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:33 PM
SELLAS Life Sciences Group (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:33 PM
SELLAS Life Sciences Group (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:34 PM
SCHEINBERG DAVID A (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:34 PM
SELLAS Life Sciences Group (Issuer)
Stergiou Angelos M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:34 PM
Burns John Thomas (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:45 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:05 PM
Burns John Thomas (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:05 PM
SELLAS Life Sciences Group (Issuer)
Stergiou Angelos M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:06 PM
CICIC DRAGAN (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:17 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:01 PM
SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
7:33 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
SELLAS Life Sciences Group (Subject)
Form SC 13G/A
10/04/2024
3:06 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:12 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:42 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:26 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:01 PM
SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
11:16 PM
SELLAS Life Sciences Group (Filer)
Form EFFECT
05/01/2024
11:16 PM
SELLAS Life Sciences Group (Filer)
Form EFFECT
04/29/2024
3:16 PM
SELLAS Life Sciences Group (Filer)
Form S-3/A
03/28/2024
3:46 PM
SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:51 PM
SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:08 PM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM
SELLAS Life Sciences Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:45 AM
SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:37 PM
SELLAS Life Sciences Group (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLS) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners